BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 5, 2010
View Archived Issues
Eisai reports third quarter 2009 results
Read More
Prolor reports topline results from phase I study of CTP-modified human growth hormone
Read More
ChemoCentryx initiates phase I clinical trial of CCX-168 for autoimmune diseases
Read More
FDA approves Beech Tree's IND for phase I/IIa clinical trial of influenza drug BTL-TML-001
Read More
In vivo antiatherosclerotic effects of liver-selective thyromimetic support its clinical evaluation
Read More
Figitumumab safe and effective in phase I trial in adrenocortical carcinoma patients
Read More
Good safety profile of ciclosporin seen in severe traumatic brain injury patients
Read More
Conatus initiates phase II trial of CTS-1027 in combination with Pegasys and Copegus in HCV
Read More
Vertex reports preliminary results from phase IIa clinical trial of VX-809 in cystic fibrosis
Read More
GlaxoSmithKline discloses new agents for treating Flaviviridae virus infections
Read More
Faes Farma discloses novel anti-inflammatory compounds
Read More
Swissmedic approves BTG's DigiFab for life-threatening digitalis intoxication
Read More
Allergan presents new prostanoid EP2 receptor agonists
Read More
FDA accepts for filing Teva's BLA for XM-02 in neutropenia
Read More
Nano-sized conjugates with antiangiogenic activity disclosed by Ramot
Read More
Novel HDAC inhibitors identified by Karus Therapeutics
Read More
Isogenica and Phylogica sign partnership agreement for CIS display and Phylomer peptides
Read More
Apeiron and GSK sign agreement for enzyme biotherapeutic APN-01 for ARDS
Read More
Compugen discovers CGEN-15001 for treatment of autoimmune disorders
Read More
Stem Cell Therapy International and Histostem complete merger
Read More
ACT and University of Louisville sign agreement for identification of cancer drug candidates
Read More
United Therapeutics and Mondobiotech enter into global strategic partnership for aviptadil
Read More
Tanezumab relieves pain in three chronic conditions
Read More
Tapentadol IR and ER can be converted to equivalent daily doses
Read More
FDA approves Keryx's SPA for phase III X-PECT trial of perifosine in colorectal cancer
Read More